Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004035:Diet Therapy; D004992:Ethics, Medical; D005260:Female; D006306:Health Surveys; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood / Q000627:therapeutic use; D008297:Male; D010629:Phenformin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D010629:Phenformin